Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Diabetes Mellitus, Type 2

phenylmethylsulfonyl fluoride has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khosravi, J1
Diamandi, A1
Bodani, U1
Khaja, N1
Krishna, RG1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Diabetes Mellitus, Type 2

ArticleYear
Pitfalls of immunoassay and sample for IGF-I: comparison of different assay methodologies using various fresh and stored serum samples.
    Clinical biochemistry, 2005, Volume: 38, Issue:7

    Topics: Adult; Aged; Aprotinin; Diabetes Mellitus, Type 2; Endopeptidases; Enzyme-Linked Immunosorbent Assay

2005